• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于不明原因或轻度男性因素不育的夫妇,首次提供体外受精(IVF)与首次提供宫腔内人工授精(IUI)随后(针对IUI失败情况)进行体外受精的成本效益比较。

Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertility.

作者信息

Pashayan Nora, Lyratzopoulos Georgios, Mathur Raj

机构信息

Department of Public Health and Primary Care, Institute of Public Health, University Forvie Site, Robinson Way, Cambridge CB2 2SR, UK.

出版信息

BMC Health Serv Res. 2006 Jun 23;6:80. doi: 10.1186/1472-6963-6-80.

DOI:10.1186/1472-6963-6-80
PMID:16796733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1543624/
Abstract

BACKGROUND

In unexplained and mild male factor subfertility, both intrauterine insemination (IUI) and in-vitro fertilisation (IVF) are indicated as first line treatments. Because the success rate of IUI is low, many couples failing IUI subsequently require IVF treatment. In practice, it is therefore important to examine the comparative outcomes (live birth-producing pregnancy), costs, and cost-effectiveness of primary offer of IVF, compared with primary offer of IUI followed by IVF for couples failing IUI.

METHODS

Mathematical modelling was used to estimate comparative clinical and cost effectiveness of either primary offer of one full IVF cycle (including frozen cycles when applicable) or "IUI + IVF" (defined as primary IUI followed by IVF for IUI failures) to a hypothetical cohort of subfertile couples who are eligible for both treatment strategies. Data used in calculations were derived from the published peer-reviewed literature as well as activity data of local infertility units.

RESULTS

Cost-effectiveness ratios for IVF, "unstimulated-IUI (U-IUI) + IVF", and "stimulated IUI (S-IUI) + IVF" were 12,600 pounds sterling, 13,100 pound sterling and 15,100 pound sterling per live birth-producing pregnancy respectively. For a hypothetical cohort of 100 couples with unexplained or mild male factor subfertility, compared with primary offer of IVF, 6 cycles of "U-IUI + IVF" or of "S-IUI + IVF" would cost an additional 174,200 pounds sterling and 438,000 pounds sterling, representing an opportunity cost of 54 and 136 additional IVF cycles and 14 to 35 live birth-producing pregnancies respectively.

CONCLUSION

For couples with unexplained and mild male factor subfertility, primary offer of a full IVF cycle is less costly and more cost-effective than providing IUI (of any modality) followed by IVF.

摘要

背景

在不明原因的轻度男性因素不育症中,宫腔内人工授精(IUI)和体外受精(IVF)均被列为一线治疗方法。由于IUI的成功率较低,许多接受IUI治疗失败的夫妇随后需要进行IVF治疗。因此,在实际操作中,对于不明原因或轻度男性因素不育且符合两种治疗策略的夫妇,比较首次提供IVF与先提供IUI然后对IUI失败的夫妇进行IVF的相对结果(产生活产的妊娠)、成本和成本效益非常重要。

方法

采用数学模型来估计对一组符合两种治疗策略的不育夫妇首次提供一个完整的IVF周期(适当时包括冷冻周期)或“IUI+IVF”(定义为先进行IUI,然后对IUI失败的夫妇进行IVF)的相对临床效果和成本效益。计算中使用的数据来自已发表的同行评审文献以及当地不孕不育治疗机构的活动数据。

结果

IVF、“非刺激IUI(U-IUI)+IVF”和“刺激IUI(S-IUI)+IVF”每例产生活产的妊娠的成本效益比分别为12,600英镑、13,100英镑和15,100英镑。对于一组假设的100对不明原因或轻度男性因素不育的夫妇,与首次提供IVF相比,6个周期的“U-IUI+IVF”或“S-IUI+IVF”将额外花费174,200英镑和438,000英镑,分别代表54个和136个额外IVF周期的机会成本,以及分别14至35例产生活产的妊娠。

结论

对于不明原因和轻度男性因素不育的夫妇,首次提供一个完整的IVF周期比先提供任何方式的IUI然后进行IVF成本更低且更具成本效益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb9/1543624/3a18f185e57f/1472-6963-6-80-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb9/1543624/491260408238/1472-6963-6-80-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb9/1543624/3a18f185e57f/1472-6963-6-80-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb9/1543624/491260408238/1472-6963-6-80-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb9/1543624/3a18f185e57f/1472-6963-6-80-2.jpg

相似文献

1
Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertility.对于不明原因或轻度男性因素不育的夫妇,首次提供体外受精(IVF)与首次提供宫腔内人工授精(IUI)随后(针对IUI失败情况)进行体外受精的成本效益比较。
BMC Health Serv Res. 2006 Jun 23;6:80. doi: 10.1186/1472-6963-6-80.
2
Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?试管婴儿服务有两种不同方式——比控制性卵巢过度刺激下的宫腔内人工授精更具成本效益吗?
Hum Reprod. 2015 Oct;30(10):2331-9. doi: 10.1093/humrep/dev193. Epub 2015 Aug 12.
3
Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis.特发性不孕和男性不育的宫内人工授精或体外受精:一项随机试验和成本效益分析。
Lancet. 2000 Jan 1;355(9197):13-8. doi: 10.1016/S0140-6736(99)04002-7.
4
IVF with planned single-embryo transfer versus IUI with ovarian stimulation in couples with unexplained subfertility: an economic analysis.不明原因不孕夫妇中,计划单胚胎移植的 IVF 与卵巢刺激的 IUI 比较:一项经济学分析。
Reprod Biomed Online. 2014 Mar;28(3):336-42. doi: 10.1016/j.rbmo.2013.10.021. Epub 2013 Dec 1.
5
A randomised controlled trial of intra-uterine insemination versus in vitro fertilisation in patients with idiopathic or mild male infertility.一项针对特发性或轻度男性不育患者的宫内人工授精与体外受精的随机对照试验。
Aust N Z J Obstet Gynaecol. 2014 Apr;54(2):156-61. doi: 10.1111/ajo.12168. Epub 2014 Feb 28.
6
The INeS study: prevention of multiple pregnancies: a randomised controlled trial comparing IUI COH versus IVF e SET versus MNC IVF in couples with unexplained or mild male subfertility.INE 研究:预防多胎妊娠:一项比较不明原因或轻度男性不育夫妇中 IUI COH、IVF e SET 和 MNC IVF 的随机对照试验。
BMC Womens Health. 2009 Dec 18;9:35. doi: 10.1186/1472-6874-9-35.
7
Can we identify subfertile couples that benefit from immediate in vitro fertilisation over intrauterine insemination?我们能否识别出相较于宫内授精,从即刻体外受精中获益的亚生育夫妇?
Eur J Obstet Gynecol Reprod Biol. 2016 Jul;202:36-40. doi: 10.1016/j.ejogrb.2016.04.024. Epub 2016 Apr 30.
8
Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation.不明原因不孕且预后不良的夫妇:一项比较体外受精联合选择性单胚胎移植与控制性卵巢刺激下宫腔内人工授精有效性的随机试验。
Fertil Steril. 2011 Nov;96(5):1107-11.e1. doi: 10.1016/j.fertnstert.2011.08.005. Epub 2011 Sep 3.
9
Is in vitro fertilisation more effective than stimulated intrauterine insemination as a first-line therapy for subfertility? A cohort analysis.作为不孕症的一线治疗方法,体外受精是否比促排卵宫内人工授精更有效?一项队列分析。
Aust N Z J Obstet Gynaecol. 2010 Jun;50(3):280-8. doi: 10.1111/j.1479-828X.2010.01155.x.
10
IVF or IUI as first-line treatment in unexplained subfertility: the conundrum of treatment selection markers.体外受精或宫腔内人工授精作为不明原因亚生育力的一线治疗:治疗选择标志物的难题
Hum Reprod. 2017 May 1;32(5):1028-1032. doi: 10.1093/humrep/dex037.

引用本文的文献

1
Valuing infertility treatment: Why QALYs are inadequate, and an alternative approach to cost-effectiveness thresholds.重视不孕治疗:为何质量调整生命年(QALYs)并不充分,以及成本效益阈值的替代方法。
Front Med Technol. 2022 Dec 23;4:1053719. doi: 10.3389/fmedt.2022.1053719. eCollection 2022.
2
Intrauterine insemination + controlled ovarian hyperstimulation versus in vitro fertilisation in unexplained infertility: a systematic review and meta-analysis.宫腔内人工授精联合控制性卵巢超排卵与体外受精在不明原因不孕中的应用:系统评价和荟萃分析。
Arch Gynecol Obstet. 2022 Apr;305(4):805-824. doi: 10.1007/s00404-021-06277-3. Epub 2021 Oct 12.
3

本文引用的文献

1
[Intrauterine insemination: state-of-the-art in humans].[宫内人工授精:人类的最新技术]
Gynecol Obstet Fertil. 2004 Oct;32(10):873-9. doi: 10.1016/j.gyobfe.2004.08.015.
2
IUI and evidence-based medicine: an urgent need for translation into our clinical practice.宫腔内人工授精与循证医学:迫切需要转化为我们的临床实践。
Gynecol Obstet Invest. 2005;59(1):1-2. doi: 10.1159/000080491. Epub 2004 Aug 27.
3
Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility. Current best evidence for the advanced treatment of unexplained subfertility.
Observational retrospective study of UK national success, risks and costs for 319,105 IVF/ICSI and 30,669 IUI treatment cycles.
对英国 319105 个 IVF/ICSI 和 30669 个 IUI 治疗周期的全国成功率、风险和成本的观察性回顾性研究。
BMJ Open. 2020 Mar 16;10(3):e034566. doi: 10.1136/bmjopen-2019-034566.
4
Intrauterine Insemination: Fundamentals Revisited.宫内人工授精:基础再探讨。
J Obstet Gynaecol India. 2017 Dec;67(6):385-392. doi: 10.1007/s13224-017-1060-x. Epub 2017 Oct 25.
5
Double versus single homologous intrauterine insemination for male factor infertility: a systematic review and meta-analysis.双次 versus 单次同源宫腔内人工授精治疗男性因素不孕:系统评价和荟萃分析。
Asian J Androl. 2013 Jul;15(4):533-8. doi: 10.1038/aja.2013.4. Epub 2013 May 27.
6
In vitro fertilization and multiple pregnancies: an evidence-based analysis.体外受精与多胎妊娠:一项基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(18):1-63. Epub 2006 Oct 1.
7
The potential use of intrauterine insemination as a basic option for infertility: a review for technology-limited medical settings.宫内人工授精作为不孕症基本治疗选择的潜在应用:针对技术受限医疗环境的综述
Obstet Gynecol Int. 2009;2009:584837. doi: 10.1155/2009/584837.
8
Stimulated intrauterine insemination (SIUI) and donor insemination (DI) as first line management for a selected subfertile population: the Manchester experience.对于特定的亚生育人群,将刺激子宫内人工授精(SIUI)和供体人工授精(DI)作为一线治疗方法:曼彻斯特的经验。
J Assist Reprod Genet. 2008 Sep-Oct;25(9-10):431-6. doi: 10.1007/s10815-008-9251-0. Epub 2008 Oct 1.
刺激子宫内授精并非治疗不明原因亚生育力的自然选择。目前关于不明原因亚生育力先进治疗的最佳证据。
Hum Reprod. 2003 May;18(5):907-12. doi: 10.1093/humrep/deg170.
4
Oral versus injectable ovulation induction agents for unexplained subfertility.口服与注射用排卵诱导剂治疗不明原因的亚生育力
Cochrane Database Syst Rev. 2002;2002(3):CD003052. doi: 10.1002/14651858.CD003052.
5
Why model coronary heart disease?为什么要对冠心病进行建模?
Eur Heart J. 2002 Jan;23(2):110-6. doi: 10.1053/euhj.2001.2681.
6
Controlled ovarian hyperstimulation and intrauterine insemination for treatment of unexplained infertility should be limited to a maximum of three trials.控制性卵巢过度刺激及宫腔内人工授精治疗不明原因不孕症时,试验次数应限制在最多三次。
Fertil Steril. 2001 Jan;75(1):88-91. doi: 10.1016/s0015-0282(00)01641-1.
7
Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis.特发性不孕和男性不育的宫内人工授精或体外受精:一项随机试验和成本效益分析。
Lancet. 2000 Jan 1;355(9197):13-8. doi: 10.1016/S0140-6736(99)04002-7.
8
Evaluation of the relative cost-effectiveness of treatments for infertility in the UK.英国不孕症治疗的相对成本效益评估。
Hum Reprod. 2000 Jan;15(1):95-106. doi: 10.1093/humrep/15.1.95.
9
The hospital of the future. Better out than in? Alternatives to acute hospital care.未来医院。与其住院,不如出院?急性医院护理的替代方案。
BMJ. 1999 Oct 23;319(7217):1127-30. doi: 10.1136/bmj.319.7217.1127.
10
Influence of age, diagnosis, and cycle number on pregnancy rates with gonadotropin-induced controlled ovarian hyperstimulation and intrauterine insemination.年龄、诊断及周期数对促性腺激素诱导的控制性卵巢过度刺激和宫腔内人工授精妊娠率的影响。
Fertil Steril. 1999 Sep;72(3):500-4. doi: 10.1016/s0015-0282(99)00300-3.